UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive Factors for Residual Disease After Conization in Cervical Cancer

Annals of surgical oncology, 2021-10, Vol.28 (11), p.6673-6681

2021

Volltextzugriff (PDF)

The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer

Annals of surgical oncology, 2017-12, Vol.24 (13), p.3981-3987

2017

Volltextzugriff (PDF)

Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis

International journal of gynecological cancer, 2022-03, Vol.32 (3), p.239-245

2022

Volltextzugriff (PDF)

Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation

Annals of surgical oncology, 2020-08, Vol.27 (8), p.2822-2826

2020

Volltextzugriff (PDF)

Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer

Annals of surgical oncology, 2020-05, Vol.27 (5), p.1589-1594

2020

Volltextzugriff (PDF)

Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression

BMC cancer, 2023-07, Vol.23 (1), p.613-613, Article 613

2023

Volltextzugriff (PDF)

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma

Journal of Gynecologic Oncology, 2023, 34(3), , pp.1-12

2023

Volltextzugriff (PDF)

The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score

International journal of gynecological cancer, 2016-03, Vol.26 (3), p.449-455

2016

Volltextzugriff (PDF)

Impact of Sentinel Node Mapping in Decreasing the Risk of Lymphocele in Endometrial Cancer

Annals of surgical oncology, 2021-06, Vol.28 (6), p.3293-3299

2021

Volltextzugriff (PDF)

Progression-free survival in the ICON8 trial

The Lancet (British edition), 2020-09, Vol.396 (10253), p.756-757

2020

Volltextzugriff (PDF)

Is parametrectomy always necessary in early-stage cervical cancer?

Gynecologic oncology, 2017-07, Vol.146 (1), p.16-19

2017

Volltextzugriff (PDF)

Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis

Annals of surgical oncology, 2016-04, Vol.23 (4), p.1294-1301

2016

Volltextzugriff (PDF)

Para‐aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis

Journal of surgical oncology, 2017-08, Vol.116 (2), p.220-226

2017

Volltextzugriff (PDF)

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma

International journal of molecular sciences, 2022-11, Vol.23 (23), p.14687

2022

Volltextzugriff (PDF)

ASO Author Reflections: Personalized Surgery in Recurrent Ovarian Cancer Patients

Annals of surgical oncology, 2021-07, Vol.28 (7), p.3646-3647

2021

Volltextzugriff (PDF)

Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets

Seminars in cancer biology, 2021-12, Vol.77, p.29-41

2021

Volltextzugriff (PDF)

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery

Annals of surgical oncology, 2021-07, Vol.28 (7), p.3637-3645

2021

Volltextzugriff (PDF)

Prostaglandin D2 expression is prognostic in high‑grade serous ovarian cancer

Oncology reports, 2019-04, Vol.41 (4), p.2254-2264

2019

Volltextzugriff (PDF)

Risk factors for pelvic and distant recurrence in locally advanced cervical cancer

European journal of obstetrics & gynecology and reproductive biology, 2019-04, Vol.235, p.6-12

2019

Volltextzugriff (PDF)

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

BMC cancer, 2021-05, Vol.21 (1), p.525-525, Article 525

2021

Volltextzugriff (PDF)

Immunohistochemical expression of ErbB/HER family proteins in patients with vulvar cancer

International journal of gynecology and obstetrics, 2022-04, Vol.157 (1), p.102-109

2022

Volltextzugriff (PDF)

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition

Current oncology (Toronto), 2022-01, Vol.29 (2), p.411-422

2022

Volltextzugriff (PDF)

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma

Journal of gynecologic oncology, 2023-05, Vol.34 (3), p.1-12

2023

Volltextzugriff (PDF)

Prognostic factors for overall survival and distant metastasis free survival in cervical cancer patients with locally advanced disease and the role of consolidation chemotherapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e17004-e17004

2016

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictive Factors for Residual Disease After Conization in Cervical Cancer

The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer

Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis

Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation

Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer

Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma

The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score

Impact of Sentinel Node Mapping in Decreasing the Risk of Lymphocele in Endometrial Cancer

Progression-free survival in the ICON8 trial

Is parametrectomy always necessary in early-stage cervical cancer?

Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis

Para‐aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma

ASO Author Reflections: Personalized Surgery in Recurrent Ovarian Cancer Patients

Genomic profiling of platinum-resistant ovarian cancer: The road into druggable targets

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery

Prostaglandin D2 expression is prognostic in high‑grade serous ovarian cancer

Risk factors for pelvic and distant recurrence in locally advanced cervical cancer

Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort

Immunohistochemical expression of ErbB/HER family proteins in patients with vulvar cancer

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma

Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer

Prognostic factors for overall survival and distant metastasis free survival in cervical cancer patients with locally advanced disease and the role of consolidation chemotherapy

Suchergebnisse filtern